Paclitaxel with or without pazopanib in ovarian cancer patients with relapse during bevacizumab maintenance therapy: The GINECO randomized phase II TAPAZ study

Affiliation auteurs!!!! Error affiliation !!!!
TitrePaclitaxel with or without pazopanib in ovarian cancer patients with relapse during bevacizumab maintenance therapy: The GINECO randomized phase II TAPAZ study
Type de publicationJournal Article
Year of Publication2020
AuteursF. Lobbedez J, Fabbro M., Berton D., Lequesne J., Anota A., Puszkiel A., Floquet A., Cancel M., Bourgeois H., L. Lefevre B, You B., Pommeret F., Lortholary A., Spaeth D., Martin-babau J., Abdeddaim C., Kaminsky-Forrett M-C., Petran D., M. Gross P, Brachet P-E.
JournalANNALS OF ONCOLOGY
Volume31
PaginationS611-S612
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN0923-7534
DOI10.1016/j.annonc.2020.08.947